Is lower extremity revascularization worthwhile in patients with end-stage renal disease?

摘要: Abstract Background. The purpose of this study was to review the results lower extremity revascularization in patients with end-stage renal disease and determine these functional benefit cost an aggressive approach limb preservation. Methods. During a 5-year period at our institution, 33 bypass operations were performed on 31 limbs 23 dialysis-dependent patients. Indications for limited (18) or extensive (12) tissue loss ischemia without (3). Procedures included aortobifemoral (1), femoropopliteal (10), femorotibial/pedal (22). A digital transmetatarsal amputation 57% limbs. Results. 30-day primary patency 100%. Cumulative secondary rates 2 years 65% 79%, respectively. Limb salvage 67% 59% 1 years, Patient survival poor (47% years). Peritoneal dialysis predictive ( P =.027). Only 39% salvaged year compared 78% 100% no loss, average hospital $44,308 per salvage. Conclusions. Although ischemic can be achieved excellent initial graft reasonable salvage, patient is costs are high. selective complicated may indicated. For treated peritoneal those preferred approach. (Surgery 2000;128:472–9.)